DOI:
10.1039/C6RA03771B
(Communication)
RSC Adv., 2016,
6, 48375-48378
Tandem approach for the synthesis of 3-sulfenylimidazo[1,5-a]pyridines from dithioesters†
Received
10th February 2016
, Accepted 10th May 2016
First published on 12th May 2016
Abstract
Iodine-mediated synthesis of 3-sulfenylimidazo[1,5-a]pyridines via C–H functionalization has been achieved using dithioesters, 2-methylaminopyridines and sulfonyl hydrazides. A library of 3-sulfanylimidazopyridines and imidazopyridines with broad functionalities are synthesized under metal-free reaction conditions.
The development of C–S bond formation has gained much attention in organic synthesis due to the occurrence of the C–S bond in biologically and pharmaceutically active organic materials.1 Sulfenylated heteroarenes can be found in molecules such as AZD4407, a 5-lipoxygenase inhibitor,2 and thienoacene-based materials (Fig. 1).3 Pharmacological properties of imidazopyridines are mainly dependent on the nature of the substituents, and introduction of sulfenyl or selenyl groups on the aza-aromatic rings could impart marked biological properties to the compounds; for example, 3-sulfenyl indoles, 3-sulfenyl pyrroles, and 3-sulfenylimidazopyridines are of considerable therapeutic value against a variety of diseases.4 3-Sulfenylimidazopyridines are usually prepared by sulfenylation of imidazopyridines prior-synthesized. Direct formation of a C–S bond via C–H functionalization of heterocycles has received considerable attention in recent years. Thiols,5 disulfides,6 N-thioimides,7 arylsulfonyl chlorides,8 sulfonium salts9 etc. have been used as the sulfenylating agents. The use of these reagents has some practical limitations such as thiols are foul-smelling, volatile, and toxic, where as disulfides are expensive, moisture sensitive and unstable. In addition, these methodologies suffer from some drawbacks like the use of a transition metal catalyst, stoichiometric amounts of oxidants and bases, harsh reaction conditions, and limited applicability.
 |
| Fig. 1 Biologically active sulfenylated heteroarenes; (a) 5-lipoxygenase inhibitor and (b) inhibitor HIV-1 integrase. | |
Sulfonyl hydrazides are readily accessible and exist as stable solids, and they have been widely employed to form hydrazones and heterocycles which have versatile applications.10 Moreover, sulfonyl hydrazides can be utilized as reductants11 and sulfonyl sources12 through the cleavage of their sulfur–nitrogen bonds, and very recently as aryl sources through the cleavage of their carbon–sulfur bonds.13 Thus, it is highly desirable to develop an alternate method for the sulfenylation of imidazo[1,5-a]pyridines under transition metal free condition. Tian and coworkers first reported the thiolation of indoles employing sulfonyl hydrazides as a thiol surrogate.14 Subsequently, Singh et al. also reported the synthesis of vinyl sulfides and diaryl thioethers using sulfonyl hydrazides under microwave irradiation.15 Very recently Hajra and co-workers reported the thiolation of imidazo[1,2-a]pyridines using sulfonyl hydrazides.16 So far, the use of sulfonyl hydrazides as sulfenylating agents is limited. Recently, we have reported a method for the synthesis of functionalized imidazopyridine derivatives employing novel method.17 Based on our experiences on dithioesters18 and inspired by Tian's pioneering work, we have envisaged that imidazo[1,5-a]pyridines could be sulfenylated at the 3-position under mild conditions. In continuation of our work on synthesis of heterocyclic compounds19 herein, we report a new iodine-mediated convenient and tandem approach for the synthesis of 3-sulfenylimidazo[1,5-a]pyridines under mild conditions by sulfonyl hydrazides as a thiol surrogate.
Result and discussion
We set out to identify the possible mild reaction conditions for the model reaction between 2-methylaminopyridine, p-toluenesulfonyl hydrazide and phenyl dithioester and results are listed in Table 1.
Table 1 Reaction optimization of 4aa

|
No. |
Additives |
Solvent |
Time in h |
Temperature |
Yield% |
Reactions were performed with 1.1 mmol of 1a and 1.0 mmol of 2a. Yields are isolated yields of chromatographically purified compounds. |
1 |
I2 (1.0 eq.) |
Ethanol |
12 h |
Rt |
— |
2 |
I2 (1.0 eq.) |
Ethanol |
20 h |
70 °C |
48 |
3 |
I2 (2.2 eq.) |
Ethanol |
14 h |
80 °C |
87 |
4 |
I2 (2.5 eq.) |
Ethanol |
12 h |
80 °C |
86 |
5 |
I2 (2.2 eq.) |
Methanol |
24 h |
80 °C |
75 |
6 |
I2 (2.2 eq.) |
THF |
24 h |
80 °C |
81 |
7 |
I2 (2.2 eq.) |
DMF |
24 h |
80 °C |
60 |
8 |
I2 (2.2 eq.) |
CH3CN |
24 h |
80 °C |
78 |
9 |
I2 (2.2 eq.) |
Ethyl acetate |
20 h |
80 °C |
67 |
10 |
I2 (2.2 eq.) |
CHCl3 |
18 h |
80 °C |
55 |
11 |
I2 (2.2 eq.) |
CH2Cl2 |
24 h |
80 °C |
30 |
12 |
TBAI (2.0 eq.) |
Ethanol |
24 h |
80 °C |
55 |
13 |
NIS (2.0 eq.) |
Ethanol |
24 h |
80 °C |
43 |
Initially the reaction was carried out using 1.0 eq. of I2 as an additive at room temperature. Gratifyingly, the 2-phenylimidazo[1,5-a]pyridine was obtained with 46% yield after 12 h. Inspired by this result, the reaction of p-toluenesulfonyl hydrazide, phenyl dithioester and 2-methylaminopyridine was stirred at 50 °C for 12 h which again formed 2-phenylimidazo[1,5-a]pyridine with 55% yield but failed to produce sulfonated product. The desired sulfonated product 3-sulfenylimidazo[1,5-a]pyridine was obtained in 48% yield when the temperature was raised to 70 °C (Table 1, entry 2). Optimisation of additive loading was carried out to improve the yield of 4a. On increasing the additive loading to 2.2 eq. the desired product was obtained with 87% yield respectively (Table 1, entry 3). The additive failed to induce any positive impact on the yield with further enhancement of its amount to 2.5 eq. (Table 1, entry 4). Thus the additive loading was optimized at 2.2 eq. The reaction was then performed in different common solvents like MeOH, THF, DMF, MeCN, ethyl acetate, CHCl3, CH2Cl2 etc. (Table 1, entries 5–11). The better result was obtained in ethanol. Other iodide sources like TBAI and NIS were not as effective as I2 (Table 1, entries 12 and 13). Thus the highest yield (87%) was obtained in the presence of 2.2 eq. of I2 in ethanol at 80 °C (Table 1, entry 3).
With the optimized reaction conditions in hand, the substrate scope was investigated and the results are shown in Scheme 1. Remarkable tolerance toward electronic demands of substituents on both dithioesters and p-toluenesulfonyl hydrazide were studied under optimized reaction conditions. Dithioesters bearing various substituents like –Me, –F at different positions on the benzene ring was efficiently reacted with p-toluenesulfonyl hydrazide to afford the desired products with high to excellent yields (4a–4n). Dithioesters with electron donating group (4b and 4j) and electron withdrawing groups (4d) on the phenyl ring were well tolerated. The sulfonyl hydrazide bearing electron –donating groups (Me, O–Me) and electron withdrawing groups (F, NO2 and CF3) produced the desired product with high yields (Scheme 1, 4g–4l).
 |
| Scheme 1 Substrate scope for the synthesis of 3-sulfenylimidazo[1,5-a]pyridines. | |
The aliphatic sulfonyl hydrazides were successfully underwent the current reaction giving desired products under optimized reaction condition (Scheme 1, 4m and 4n). The structure is also confirmed by single X-ray crystal studies for the compound 4h.
To extend the scope of the methodology, a variety of dithioesters were allowed to react with 2-methylamino pyridine or hydrazine pyridine. Without the use of phenyl sulfonyl hydrazides, iodine mediated reaction of dithioesters and methylaminopyridine easily afforded the intermediate imidazo[1,5-a]pyridines without any oxidant. Number of protocols has been developed to synthesize imidazopyridines,20–23 which suffers from disadvantages like the use of strong acidic, corrosive reagents such as POCl3,20a SOCl2,20b Lawesson's reagent21a and a modified Mitsunobu reaction.21b In contrast to the above methods, the present protocol provides a novel method for the synthesis of imidazolopyridine in high yields under mild condition and simple work up procedures.
Insight of this and as result of great importance of functionalized imidazopyridines among natural and pharmaceutical products, we explored out a procedure with several kinds of substrates and the results are shown in Scheme 2.
 |
| Scheme 2 Substrate scope for the synthesis of imidazolo[1,5-a]pyridines and [1,2,4]-triazolo[4,3-a]pyridines. | |
A plausible mechanism for the cyclization reaction leading to imidazolo[1,5-a]pyridines is displayed in Scheme 3. The reaction of 2-methylaminopyridine 2 with phenyl dithioester 1 gives N-2-pyridylmethyl thioamide A followed by the iodination at sulfur generates intermediate B. Subsequent iodination again at sulfur takes place to form an electrophilic intermediate C, which undergoes intramolecular substitution by the pyridine nitrogen at the immino carbon to form D. Finally, the aromatization of D takes place to yield the product 5.
 |
| Scheme 3 A plausible reaction mechanism for the formation of imidazolo[1,5-a]pyridines. | |
Conclusions
An efficient I2-mediated three-component reaction in one pot has been developed for the synthesis of 3-sulfenylimidazopyridines from dithioesters, 2-aminopyridines, and sulfonyl hydrazides. This tandem reaction process involves a C–H bond functionalization strategy for the formation of C–N and C–S bonds without any oxidants. The reaction proceeds through the cleavage of sulfur–nitrogen and sulfur–oxygen bonds by sulfonyl hydrazides as a thiol surrogate in. This methodology is applicable to both alkyl and aryl sulfonyl hydrazides, and various imidazopyridines having broad functionalities. Simple, one pot, broad substrate scope, transition metal free and mild reaction conditions are the attractive features of the present protocol. In addition, imidazopyridines can also be formed under the optimized reaction conditions without the use of disulfides.
Acknowledgements
Financial support from the DST-Fastrack, New Delhi (grant No. SERB/F/5061/2013-14 dated 31-10-2013) is gratefully acknowledged. We also thank NMR Facility, Institute of Excellence, University of Mysore, Manasagangotri, Mysuru-570006, India for spectral data.
Notes and references
-
(a) A. Casini, J. Y. Winum, J. L. Montero, A. Scozzafava and C. T. Supuran, Bioorg. Med. Chem. Lett., 2003, 13, 837 CrossRef CAS PubMed;
(b) M. Mellah, A. Voituriez and E. Schulz, Chem. Rev., 2007, 107, 5133 CrossRef CAS PubMed;
(c) A. R. Murphy and J. M. J. Frchet, Chem. Rev., 2007, 107, 1066 CrossRef CAS PubMed;
(d) T. Mori, T. Nishimura, T. Yamamoto, I. Doi, E. Miyazaki, I. Osaka and K. Takimiya, J. Am. Chem. Soc., 2013, 135, 13900 CrossRef CAS PubMed.
-
(a) S. Pasquini, C. Mugnaini, C. Tintori, M. Botta, A. Trejos, R. K. Arvela, M. Larhed, M. Witvrouw, M. Michiels, F. Christ, Z. Debyser and F. Corelli, J. Med. Chem., 2008, 51, 5125 CrossRef CAS PubMed;
(b) M.-L. Alcaraz, S. Atkinson, P. Cornwall, A. C. Foster, D. M. Gill, L. A. Humphries, P. S. Keegan, R. Kemp, E. Merifield, R. A. Nixon, A. J. Noble, D. OlBeirne, Z. M. Patel, J. Perkins, P. Rowan, P. Sadler, J. T. Singleton, J. Tornos, A. J. Watts and I. A. Woodland, Org. Process Res. Dev., 2005, 9, 555 CrossRef CAS;
(c) R. L. Beard, D. F. Colon, T. K. Song, P. J. A. Davies, D. M. Kochhar and R. A. S. Chandraratna, J. Med. Chem., 1996, 39, 3556 CrossRef CAS PubMed;
(d) Y. Huang, S. A. Bae, Z. Zhu, N. Guo, B. L. Roth and M. Laruelle, J. Med. Chem., 2005, 48, 2559 CrossRef CAS PubMed.
-
(a) A. K. Yudin, Catalyzed Carbon-Heteroatom Bond Formation, Wiley-VCH, Weinheim, 2012 Search PubMed;
(b) A. Vigalok, C-X Bond Formation, Springer, Heidelberg, 2010 Search PubMed;
(c) H. Liu and X. Jiang, Chem. Asian J., 2013, 8, 2546 CrossRef CAS PubMed;
(d) D. Kundu, T. Chatterjee and B. C. Ranu, Adv. Synth. Catal., 2013, 355, 2285 CrossRef CAS.
-
(a) K. Takimiya, I. Osaka, T. Mori and M. Nakano, Acc. Chem. Res., 2014, 47, 1493 CrossRef CAS PubMed;
(b) T. Okamoto, C. Mitsui, M. Yamagishi, K. Nakahara, J. Soeda, Y. Hirose, K. Miwa, H. Sato, A. Yamano, T. Matsushita, T. Uemura and J. Takeya, Adv. Mater., 2013, 25, 6392 CrossRef CAS PubMed;
(c) K. Takimiya, S. Shinamura, I. Osaka and E. Miyazaki, Adv. Mater., 2011, 23, 4347 CrossRef CAS PubMed;
(d) J. E. Anthony, Chem. Rev., 2006, 106, 5028 CrossRef CAS PubMed.
-
(a) O. Saidi, J. Marafie, A. E. W. Ledger, P. M. Liu, M. F. Mahon, G. Kociok-Kohn, M. K. Whittlesey and C. G. Frost, J. Am. Chem. Soc., 2011, 133, 19298 CrossRef CAS PubMed;
(b) K. M. Schlosser, A. P. Krasutsky, H. W. Hamilton, J. E. Reed and K. Sexton, Org. Lett., 2004, 6, 819 CrossRef CAS PubMed;
(c) M. Tudge, M. Tamiya, C. Savarin and G. R. Humphrey, Org. Lett., 2006, 8, 565 CrossRef CAS PubMed.
- D. Huang, J. Chen, W. Dan, J. Ding, M. Liu and H. Wu, Adv. Synth. Catal., 2012, 354, 2123 CrossRef CAS.
-
(a) W. Ge and Y. Wei, Synthesis, 2012, 934 CAS;
(b) W. Ge and Y. Wei, Green Chem., 2012, 14, 2066 RSC;
(c) Z. Li, J. Hong and X. Zhou, Tetrahedron, 2011, 67, 3690 CrossRef CAS;
(d) X.-L. Fang, R.-Y. Tang, P. Zhong and J.-H. Li, Synthesis, 2009, 4183 CAS;
(e) C. C. Browder, M. O. Mitchell, R. L. Smith and G. el-Stdayman, Tetrahedron Lett., 1993, 34, 6245 CrossRef CAS.
-
(a) E. Marcantoni, R. Cipolletti, L. Marsili, S. Menichetti, R. Properzi and C. Viglianisi, Eur. J. Org. Chem., 2013, 132 CrossRef CAS;
(b) M. Tudge, M. Tamiya, C. Savarin and G. R. Humphrey, Org. Lett., 2006, 8, 565 CrossRef CAS PubMed;
(c) C. C. Silveira, S. R. Mendes, L. Wolf and G. M. Martins, Tetrahedron Lett., 2010, 51, 2014 CrossRef CAS.
- Q. Wu, D. Zhao, X. Qin, J. Lan and J. You, Chem. Commun., 2011, 47, 9188 RSC.
- S. Jain, K. Shukla, A. Mukhopadhyay, S. N. Suryawanshi and D. S. Bhakuni, Synth. Commun., 1990, 20, 1315 CrossRef CAS.
-
(a) F.-L. Yang and S.-K. Tian, Angew. Chem., Int. Ed., 2013, 52, 4929 CrossRef CAS PubMed;
(b) F.-L. Yang, F.-X. Wang, T.-T. Wang, Y.-J. Wang and S.-K. Tian, Chem. Commun., 2014, 50, 2111 RSC;
(c) N. Singh, R. Singh, D. S. Raghuvanshi and K. N. Singh, Org. Lett., 2013, 15, 5874 CrossRef CAS PubMed;
(d) R. Singh, D. S. Raghuvanshi and K. N. Singh, Org. Lett., 2013, 15, 4202 CrossRef CAS PubMed.
- For reviews, see:
(a) D. J. Pasto and R. T. Taylor, Org. React., 1991, 40, 91 CAS;
(b) D. J. Pasto, in Comprehensive Organic Synthesis, vol. 8 ed., B. M. Trost, I. Fleming, Pergamon, Oxford, 1991, p. 471 Search PubMed.
- C. Enguehard-Gueiffier and A. Gueiffier, Mini-Rev. Med. Chem., 2007, 7, 888 CrossRef CAS PubMed.
-
(a) F.-L. Yang, X.-T. Ma and S.-K. Tian, Chem.–Eur. J., 2012, 18, 1582 CrossRef CAS PubMed;
(b) B. Liu, J. Li, F. Song and J. You, Chem.–Eur. J., 2012, 18, 10830 CrossRef CAS PubMed;
(c) X. Yu, X. Li and B. Wan, Org. Biomol. Chem., 2012, 10, 7479 RSC;
(d) O. Y. Yuen, C. M. So, W. T. Wong and F. Y. Kwong, Synlett, 2012, 2714 CAS.
-
(a) N. Singh, R. Singh, D. S. Raghuvanshi and K. N. Singh, Org. Lett., 2013, 15, 5874 CrossRef CAS PubMed;
(b) R. Singh, D. S. Raghuvanshi and K. N. Singh, Org. Lett., 2013, 15, 4202 CrossRef CAS PubMed.
- A. K. Bagdi, S. Mitra, M. Ghosh and A. Hajra, Org. Biomol. Chem., 2015, 13, 3314 CAS.
- A. B. Ramesha, G. M. Raghavendra, K. N. Nandeesh, K. S. Rangappa and K. Mantelingu, Tetrahedron Lett., 2013, 54, 95 CrossRef CAS.
-
(a) S. Vijay Kumar, S. K. Yadav, B. Raghava, B. Saraiah, H. Ila, K. S. Rangappa and A. Hazra, J. Org. Chem., 2013, 78, 4960 CrossRef PubMed;
(b) T. A. Jenifer, K. N. Nandeesh, G. M. Raghavendra, K. S. Rangappa and K. Mantelingu, Tetrahedron Lett., 2013, 54, 6533 CrossRef;
(c) G. S. Lingaraju, T. R. Swaroop, A. C. Vinayaka, K. S. Sharath Kumar, M. P. Sadashiva and K. S. Rangappa, Synthesis, 2012, 44, 1373 CrossRef CAS;
(d) A. C. Vinayaka, M. P. Sadashiva, X. Wu, S. S. Biryukov, J. A. Stoute, K. S. Rangappa and D. Channe Gowda, Org. Biomol. Chem., 2014, 12, 8555 RSC;
(e) B. Raghava, G. Parameshwarappa, A. Acharya, T. R. Swaroop, K. S. Rangappa and H. Ila, Eur. J. Org. Chem., 2014, 9, 1882 CrossRef.
-
(a) K. Mantelingu, Y. Lin and D. Seidel, Org. Lett., 2014, 16, 5910 CrossRef CAS PubMed;
(b) C. S. Pavan Kumar, K. B. Harsha, N. C. Sandhya, A. B. Ramesha, K. Mantelingu and K. S. Rangappa, New J. Chem., 2015, 39, 8397 RSC;
(c) C. S. Pavan Kumar, K. B. Harsha, K. Mantelingu and K. S. Rangappa, RSC Adv., 2015, 5, 61664 RSC.
-
(a) S. W. Schneller and D. G. Bartholomew, J. Heterocycl. Chem., 1978, 15, 439 CrossRef CAS;
(b) H. Reimlinger and W. R. F. Lingier, Chem. Ber., 1975, 108, 3787 CrossRef CAS.
-
(a) A. Moulina, J. Martineza and J. A. Fehrentz, Tetrahedron Lett., 2006, 47, 7591 CrossRef;
(b) J. Y. Roberge, G. Yu, A. Mikkilineni, X. Wu, Y. Zhu, R. M. Lawrence and W. R. Ewing, ARKIVOC, 2007, xii, 132 Search PubMed;
(c) A. Reichelt, J. R. Falsey, R. M. Rzasa, O. R. Thiel, M. M. Achmatowicz, R. D. Larsen and D. Zhang, Org. Lett., 2010, 12(4), 792 CrossRef CAS PubMed.
- G. Pelletier and A. B. Charette, Org. Lett., 2013, 15, 2290 CrossRef CAS PubMed.
- J. J. Li, A. K. Trehan, H. S. Wong, S. Krishnananthan, L. J. Kennedy, Q. Gao, J. A. Robl, B. Balasubramanian and B. C. Chen, Org. Lett., 2008, 10, 2897 CrossRef CAS PubMed.
Footnote |
† Electronic supplementary information (ESI) available: 1H NMR and 13C NMR. CCDC 4h-1451828. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra03771b |
|
This journal is © The Royal Society of Chemistry 2016 |
Click here to see how this site uses Cookies. View our privacy policy here.